Ataru Igarashi

4.1k total citations
197 papers, 2.7k citations indexed

About

Ataru Igarashi is a scholar working on Economics and Econometrics, Epidemiology and Surgery. According to data from OpenAlex, Ataru Igarashi has authored 197 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Economics and Econometrics, 35 papers in Epidemiology and 22 papers in Surgery. Recurrent topics in Ataru Igarashi's work include Health Systems, Economic Evaluations, Quality of Life (48 papers), Rheumatoid Arthritis Research and Therapies (14 papers) and Pharmaceutical Economics and Policy (12 papers). Ataru Igarashi is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (48 papers), Rheumatoid Arthritis Research and Therapies (14 papers) and Pharmaceutical Economics and Policy (12 papers). Ataru Igarashi collaborates with scholars based in Japan, United States and Ireland. Ataru Igarashi's co-authors include Shunya Ikeda, Takeru Shiroiwa, Takashi Fukuda, Shinya Saito, Kojiro Shimozuma, Shinichi Noto, Kiichiro Tsutani, Takeo Nakayama, Makiko Kusama and Manabu Akazawa and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Ataru Igarashi

171 papers receiving 2.7k citations

Peers

Countries citing papers authored by Ataru Igarashi

Since Specialization

Citations

This map shows the geographic impact of Ataru Igarashi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ataru Igarashi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ataru Igarashi more than expected).

Fields of papers citing papers by Ataru Igarashi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ataru Igarashi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ataru Igarashi. The network helps show where Ataru Igarashi may publish in the future.

Co-authorship network of co-authors of Ataru Igarashi

This figure shows the co-authorship network connecting the top 25 collaborators of Ataru Igarashi. A scholar is included among the top collaborators of Ataru Igarashi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ataru Igarashi. Ataru Igarashi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	EE115 Markov Simulation for Estimating the Impact of Lecanemab Treatment on Health Outcomes in Early Alzheimer's Disease from a Japanese Societal Perspective 2025 ·Value in Health ·Ataru Igarashi, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Sachie Inoue, (unknown), Kevin Molloy, David Trueman, (unknown), (unknown), (unknown), (unknown)	0
2	Cost‐Effectiveness Analysis of Fecal Immunochemical Test‐ and Colonoscopy‐based Colorectal Cancer Screening across Varying Uptake Rates 2025 ·DEN Open ·Masau Sekiguchi, Ataru Igarashi, Minoru Esaki, Yutaka Saito, Nozomu Kobayashi, Takahisa Matsuda	0
3	The emotional burden of caring for patients with Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex-associated epilepsy: A qualitative study in Japan 2024 ·Epilepsy & Behavior ·(unknown), Ataru Igarashi, (unknown), (unknown)	3
4	A quantitative cross-sectional study of the burden of caring for patients with Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex-associated epilepsy in Japan 2024 ·Epilepsy & Behavior ·(unknown), Ataru Igarashi, (unknown), (unknown)	7
5	Comparing the effects of biguanides and dipeptidyl peptidase-4 inhibitors on cardio-cerebrovascular outcomes, nephropathy, retinopathy, neuropathy, and treatment costs in diabetic patients 2024 ·PLoS ONE ·Eiji Nakatani, (unknown), Tatsunori Satoh, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Yoshihiro Tanaka, Ataru Igarashi, Hiraku Kumamaru, Nagato Kuriyama, Akira Sugawara	4
6	The Long-Term Cost-Effectiveness of Tirzepatide 5 mg versus Dulaglutide 0.75 mg for the Treatment of People with Type 2 Diabetes in Japan 2024 ·Diabetes Therapy ·Toshihiko Aranishi, Ataru Igarashi, K. Hara, (unknown), Zhihong Cai, (unknown), (unknown), Masakazu Takeuchi, Alice Minghetti, Barnaby Hunt, Takashi Kadowaki	0
7	The potential public health impact of the respiratory syncytial virus prefusion F protein vaccine in people aged ≥60 years in Japan: results of a Markov model analysis 2024 ·Expert Review of Vaccines ·Daisuke Kurai, Akiko Mizukami, (unknown), Frederik Verelst, (unknown), Taizo Matsuki, (unknown), Ataru Igarashi	6
8	Value-based reimbursement under the inpatient prospective payment system in Japan: a review of Japan’s diagnosis procedure combination/per-diem payment system 2024 ·Journal of Medical Economics ·(unknown), Ataru Igarashi	2
9	EPH112 Prevalence, Incidence, and Patient Characteristics of Valvular Heart Disease Using the National Database of Health Insurance Claims in Japan 2023 ·Value in Health ·Ataru Igarashi, Kenji Iwasaki, (unknown)	0
10	Health-related quality of life in health states corresponding to different stages of perianal fistula associated with Crohn’s disease: a quantitative evaluation of patients and non-patients in Japan 2023 ·SHILAP Revista de lepidopterología ·Masafumi Kato, (unknown), (unknown), (unknown), Ataru Igarashi	3
11	Factors associated with financial toxicity in patients with breast cancer in Japan: a comparison of patient and physician perspectives 2023 ·Breast Cancer ·(unknown), (unknown), Atsuko Kitano, Naomi Sakurai, Yuko Tanabe, Chikako Yamauchi, Ataru Igarashi, (unknown), Sayaka Kuba, Fumikata Hara, Yasuaki Sagara, Shinji Ohno	4
12	Influence of the COVID-19 Pandemic on Overall Physician Visits and Telemedicine Use Among Patients With Type 1 or Type 2 Diabetes in Japan 2022 ·Journal of Epidemiology ·(unknown), Takehiro Sugiyama, Kosuke Inoue, Ataru Igarashi, Ryotaro Bouchi, Mitsuru Ohsugi, Kohjiro Ueki, Atsushi Goto	13
13	Health state utilities of patients with hepatitis B and C and hepatitis-related conditions in Japan 2022 ·Scientific Reports ·Hiroki Sugimori, Maki Hirao, Ataru Igarashi, Hiroshi Yatsuhashi, (unknown), Naohiko Masaki, Hiroshi Yotsuyanagi, Takeshi Yoda, Takeshi Odajima, Tomoyuki Takura, Tomohiro Hirao	2
14	Public preferences and willingness to accept a hypothetical vaccine to prevent a pandemic in Japan: a conjoint analysis 2022 ·Expert Review of Vaccines ·Ataru Igarashi, (unknown), (unknown)	9
15	Health-Related Quality of Life during COVID-19 Pandemic: Assessing Impacts of Job Loss and Financial Support Programs in Japan 2021 ·Applied Research in Quality of Life ·Takaaki Ikeda, Ataru Igarashi, Satomi Odani, (unknown), Takahiro Tabuchi	47
16	Cost-effectiveness of baloxavir marboxil compared with laninamivir for the treatment of influenza in patients at high risk for complications in Japan 2021 ·Current Medical Research and Opinion ·(unknown), (unknown), Naoya Itsumura, Nobuo Hirotsu, (unknown), Samuel Aballéa, (unknown), Mark Hill, Ataru Igarashi	7
17	Cost-effectiveness analysis of treatment regimens with obinutuzumab plus chemotherapy in Japan for untreated follicular lymphoma patients 2020 ·Journal of Medical Economics ·(unknown), Ayako Shoji, Kiyohiko Hatake, Naoko Oya, Ataru Igarashi	4
18	Impact of Adalimumab on Work Productivity and Activity Impairment in Japanese Patients with Rheumatoid Arthritis: Large-Scale, Prospective, Single-Cohort ANOUVEAU Study 2017 ·Advances in Therapy ·Tsutomu Takeuchi, Ryo Nakajima, Shuichi Komatsu, (unknown), Tomohiro Nakamura, Naoki Agata, Ataru Igarashi, Toshiro Tango, Yoshiya Tanaka	20
19	Comparison of Value Set Based on DCE and/or TTO Data: Scoring for EQ-5D-5L Health States in Japan 2016 ·Value in Health ·Takeru Shiroiwa, Shunya Ikeda, Shinichi Noto, Ataru Igarashi, Takashi Fukuda, Shinya Saito, Kojiro Shimozuma	212
20	What is ATC/DDD ? 2004 ·Kiichiro Tsutani, Ataru Igarashi, (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact